Showing results (671-680 of 7,530) with videos related to

Sort By:
Pageof 753
Scientific Reports|January 7, 2026
Bone mesenchymal stem cells-derived exosomal miR-509-5p promotes osteogenic differentiation by targeting SFRP1 and activating the Wnt/β-catenin pathwayLihua Liu, Wei Sun, Boya Li, et al.
Frontiers in Endocrinology|February 23, 2023
Nomogram for predicting central lymph node metastasis in T1-T2 papillary thyroid cancer with no lateral lymph node metastasisYubo Sun, Wei Sun, Jingzhe Xiang, et al.
Frontiers in Endocrinology|February 22, 2023
Corrigendum: Nomogram for predicting central lymph node metastasis in T1-T2 papillary thyroid cancer with no lateral lymph node metastasisYubo Sun, Wei Sun, Jingzhe Xiang, et al.
Organic & Biomolecular Chemistry|March 19, 2015
Oxidative cross-coupling of pyridine N-oxides and ethers between C(sp(2))-H/C(sp(3))-H bonds under transition-metal-free conditionsWei Sun, Zuguang Xie, Jie Liu, et al.
Plants (Basel, Switzerland)|August 14, 2025
Development of a Green-Synthesized WA-CDs@MIL-101 Fluorescent Sensor for Rapid Detection of Panax notoginseng Leaf Pathogen SporesChunhao Cao, Wei Sun, Ling Yang, et al.
Clinical Nuclear Medicine|September 12, 2025
18 F-FDG PET/CT Findings in a Patient With Uterine Inflammatory Myofibroblastic TumorChunjing Tang, Wei Sun, Zichan Long, et al.
Computer Methods in Applied Mechanics and Engineering|February 19, 2024
Synergistic Integration of Deep Neural Networks and Finite Element Method with Applications of Nonlinear Large Deformation BiomechanicsLiang Liang, Minliang Liu, John Elefteriades, et al.
International Journal of Surgery (London, England)|January 19, 2024
Clinical and molecular features of progressive papillary thyroid microcarcinomaZhiyuan Wang, Xiaoyu Ji, Hao Zhang, et al.
International Journal of Molecular Sciences|September 14, 2024
Effect of METTL3 Gene on Lipopolysaccharide Induced Damage to Primary Small Intestinal Epithelial Cells in SheepYanjun Duan, Xiaoyang Lv, Xiukai Cao, et al.
Cancer Pathogenesis and Therapy|October 7, 2024
Efficacy and toxicity of anlotinib plus camrelizumab versus anlotinib plus S-1 as second-line therapy for advanced esophageal squamous cell carcinoma: A real-world retrospective studyWei Zhang, Mingyu Chen, Hong Dai, et al.
Pageof 753